Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

TechNavio's analysts forecast the IT market in Indonesia to grow at a CAGR of 17.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing support received by the Indonesian Government. The IT market in Indonesia has also been witnessing increasing adoption of E-commerce. However, increasing piracy in the Software segment could pose a challenge to the growth of this market.

TechNavio's report, the IT Market in Indonesia 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the IT market in Indonesia landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Acer Inc., Hewlett-Packard Co., IBM Corp., Oracle Corp., and Telkomsigma.

Key questions answered in this report:

* ... Read more »